Trial Profile
Assessing Florbetaben PET Patterns in MCI Patients for an Improved Prediction of Conversion to AD.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 30 Apr 2019
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 27 Mar 2019 According to a Life Molecular Imaging, Piramal imaging changed its name to Life Molecular Imaging.
- 27 Dec 2017 New trial record